Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04478279
Title A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sapience Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
University of California, San Francisco San Francisco California 94143 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Northwestern Medicine Cancer Centers Warrenville Illinois 60555 United States Details
START Midwest Grand Rapids Michigan 49503 United States Details
Columbia University New York New York 10032 United States Details
Duke University School of Medicine Durham North Carolina 27708 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Edinburgh Cancer Centre Edinburgh EH4 2SP United Kingdom Details
The Beaston West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
University of Leeds Leeds LS9 7TF United Kingdom Details
Sarah Cannon Research Institute UK London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field